ID ATS2_HUMAN Reviewed; 1211 AA. AC O95450; DT 01-DEC-2000, integrated into UniProtKB/Swiss-Prot. DT 16-DEC-2008, sequence version 2. DT 09-DEC-2015, entry version 164. DE RecName: Full=A disintegrin and metalloproteinase with thrombospondin motifs 2; DE Short=ADAM-TS 2; DE Short=ADAM-TS2; DE Short=ADAMTS-2; DE EC=3.4.24.14; DE AltName: Full=Procollagen I N-proteinase; DE Short=PC I-NP; DE AltName: Full=Procollagen I/II amino propeptide-processing enzyme; DE AltName: Full=Procollagen N-endopeptidase; DE Short=pNPI; DE Flags: Precursor; GN Name=ADAMTS2; Synonyms=PCINP, PCPNI; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS LPNPI AND SPNPI), AND INVOLVEMENT RP IN EDS7C. RC TISSUE=Skin; RX PubMed=10417273; DOI=10.1086/302504; RA Colige A., Sieron A.L., Li S.-W., Schwarze U., Petty E., RA Wertelecki W., Wilcox W., Krakow D., Cohn D.H., Reardon W., RA Byers P.H., Lapiere C.M., Prockop D.J., Nusgens B.V.; RT "Human Ehlers-Danlos syndrome type VII C and bovine dermatosparaxis RT are caused by mutations in the procollagen I N-proteinase gene."; RL Am. J. Hum. Genet. 65:308-317(1999). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15372022; DOI=10.1038/nature02919; RA Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S., RA Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M., RA She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S., RA Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M., RA Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., RA Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M., RA Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K., RA Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C., RA Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M., RA Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A., RA Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M., RA Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M., RA Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S., RA Richardson P., Lucas S.M., Myers R.M., Rubin E.M.; RT "The DNA sequence and comparative analysis of human chromosome 5."; RL Nature 431:268-274(2004). CC -!- FUNCTION: Cleaves the propeptides of type I and II collagen prior CC to fibril assembly. Does not act on type III collagen. May also CC play a role in development that is independent of its role in CC collagen biosynthesis. CC -!- CATALYTIC ACTIVITY: Cleaves the N-propeptide of collagen chain CC alpha-1(I) at Pro-|-Gln and of alpha-1(II) and alpha-2(I) at CC Ala-|-Gln. CC -!- COFACTOR: CC Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250}; CC Note=Binds 1 zinc ion per subunit. {ECO:0000250}; CC -!- SUBUNIT: May belong to a multimeric complex. Binds specifically to CC collagen type XIV (By similarity). {ECO:0000250}. CC -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular CC matrix {ECO:0000250}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=LpNPI; CC IsoId=O95450-1; Sequence=Displayed; CC Name=SpNPI; CC IsoId=O95450-2; Sequence=VSP_005497, VSP_005498; CC Note=Has no significant N-procollagen peptidase activity.; CC -!- TISSUE SPECIFICITY: Expressed at high level in skin, bone, tendon CC and aorta and at low levels in thymus and brain. CC -!- DOMAIN: The spacer domain and the TSP type-1 domains are important CC for a tight interaction with the extracellular matrix. CC -!- PTM: The precursor is cleaved by a furin endopeptidase. CC {ECO:0000250}. CC -!- PTM: Glycosylated. Can be O-fucosylated by POFUT2 on a serine or a CC threonine residue found within the consensus sequence C1-X(2)- CC (S/T)-C2-G of the TSP type-1 repeat domains where C1 and C2 are CC the first and second cysteine residue of the repeat, respectively. CC Fucosylated repeats can then be further glycosylated by the CC addition of a beta-1,3-glucose residue by the glucosyltransferase, CC B3GALTL. Fucosylation mediates the efficient secretion of ADAMTS CC family members. Also can be C-glycosylated with one or two mannose CC molecules on tryptophan residues within the consensus sequence W- CC X-X-W of the TPRs, and N-glycosylated. These other glycosylations CC can also facilitate secretion (By similarity). {ECO:0000250}. CC -!- DISEASE: Ehlers-Danlos syndrome 7C (EDS7C) [MIM:225410]: A CC connective tissue disorder characterized by hyperextensible skin, CC atrophic cutaneous scars due to tissue fragility and joint CC hyperlaxity. Marked by extremely fragile tissues, hyperextensible CC skin and easy bruising. Facial skin contains numerous folds, as in CC the cutis laxa syndrome. {ECO:0000269|PubMed:10417273}. Note=The CC disease is caused by mutations affecting the gene represented in CC this entry. CC -!- SIMILARITY: Contains 1 disintegrin domain. {ECO:0000305}. CC -!- SIMILARITY: Contains 1 peptidase M12B domain. CC {ECO:0000255|PROSITE-ProRule:PRU00276}. CC -!- SIMILARITY: Contains 1 PLAC domain. {ECO:0000255|PROSITE- CC ProRule:PRU00233}. CC -!- SIMILARITY: Contains 4 TSP type-1 domains. {ECO:0000255|PROSITE- CC ProRule:PRU00210}. CC -!- CAUTION: Has sometimes been referred to as ADAMTS3. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AJ003125; CAA05880.1; -; mRNA. DR EMBL; AC008544; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC010216; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC109479; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR CCDS; CCDS34311.1; -. [O95450-2] DR CCDS; CCDS4444.1; -. [O95450-1] DR RefSeq; NP_055059.2; NM_014244.4. [O95450-1] DR RefSeq; NP_067610.1; NM_021599.2. [O95450-2] DR UniGene; Hs.23871; -. DR ProteinModelPortal; O95450; -. DR SMR; O95450; 268-766, 923-1010. DR BioGrid; 114887; 18. DR IntAct; O95450; 1. DR STRING; 9606.ENSP00000251582; -. DR MEROPS; M12.301; -. DR PhosphoSite; O95450; -. DR BioMuta; ADAMTS2; -. DR PaxDb; O95450; -. DR PRIDE; O95450; -. DR DNASU; 9509; -. DR Ensembl; ENST00000251582; ENSP00000251582; ENSG00000087116. [O95450-1] DR Ensembl; ENST00000274609; ENSP00000274609; ENSG00000087116. [O95450-2] DR GeneID; 9509; -. DR KEGG; hsa:9509; -. DR UCSC; uc003mjw.3; human. [O95450-1] DR UCSC; uc011dgm.2; human. [O95450-2] DR CTD; 9509; -. DR GeneCards; ADAMTS2; -. DR HGNC; HGNC:218; ADAMTS2. DR HPA; HPA028444; -. DR MalaCards; ADAMTS2; -. DR MIM; 225410; phenotype. DR MIM; 604539; gene. DR neXtProt; NX_O95450; -. DR Orphanet; 1901; Ehlers-Danlos syndrome, dermatosparaxis type. DR PharmGKB; PA24546; -. DR eggNOG; ENOG410INDA; Eukaryota. DR eggNOG; ENOG410XSRH; LUCA. DR GeneTree; ENSGT00760000118880; -. DR HOGENOM; HOG000034222; -. DR HOVERGEN; HBG004314; -. DR InParanoid; O95450; -. DR KO; K08618; -. DR OMA; IHEDSLN; -. DR OrthoDB; EOG76HQ0N; -. DR PhylomeDB; O95450; -. DR TreeFam; TF313537; -. DR Reactome; R-HSA-1650814; Collagen biosynthesis and modifying enzymes. DR Reactome; R-HSA-5173214; O-glycosylation of TSR domain-containing proteins. DR ChiTaRS; ADAMTS2; human. DR GeneWiki; ADAMTS2; -. DR GenomeRNAi; 9509; -. DR NextBio; 35632; -. DR PRO; PR:O95450; -. DR Proteomes; UP000005640; Chromosome 5. DR Bgee; O95450; -. DR CleanEx; HS_ADAMTS2; -. DR Genevisible; O95450; HS. DR GO; GO:0005576; C:extracellular region; TAS:Reactome. DR GO; GO:0005578; C:proteinaceous extracellular matrix; IEA:UniProtKB-SubCell. DR GO; GO:0004222; F:metalloendopeptidase activity; TAS:ProtInc. DR GO; GO:0008237; F:metallopeptidase activity; TAS:ProtInc. DR GO; GO:0008270; F:zinc ion binding; IEA:InterPro. DR GO; GO:0030574; P:collagen catabolic process; IEA:UniProtKB-KW. DR GO; GO:0030199; P:collagen fibril organization; IEA:Ensembl. DR GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome. DR GO; GO:0030324; P:lung development; IEA:Ensembl. DR GO; GO:0016485; P:protein processing; IEA:Ensembl. DR GO; GO:0043588; P:skin development; IEA:Ensembl. DR GO; GO:0007283; P:spermatogenesis; IEA:Ensembl. DR Gene3D; 3.40.390.10; -; 1. DR InterPro; IPR010294; ADAM_spacer1. DR InterPro; IPR024079; MetalloPept_cat_dom. DR InterPro; IPR013275; Pept_M12B_ADAM-TS2. DR InterPro; IPR001590; Peptidase_M12B. DR InterPro; IPR013273; Peptidase_M12B_ADAM-TS. DR InterPro; IPR002870; Peptidase_M12B_N. DR InterPro; IPR010909; PLAC. DR InterPro; IPR000884; TSP1_rpt. DR Pfam; PF05986; ADAM_spacer1; 1. DR Pfam; PF01562; Pep_M12B_propep; 1. DR Pfam; PF01421; Reprolysin; 1. DR Pfam; PF00090; TSP_1; 4. DR PRINTS; PR01859; ADAMTS2. DR PRINTS; PR01857; ADAMTSFAMILY. DR SMART; SM00209; TSP1; 4. DR SUPFAM; SSF82895; SSF82895; 4. DR PROSITE; PS50215; ADAM_MEPRO; 1. DR PROSITE; PS50900; PLAC; 1. DR PROSITE; PS50092; TSP1; 4. PE 2: Evidence at transcript level; KW Alternative splicing; Collagen degradation; Complete proteome; KW Disulfide bond; Ehlers-Danlos syndrome; Extracellular matrix; KW Glycoprotein; Hydrolase; Metal-binding; Metalloprotease; Polymorphism; KW Protease; Reference proteome; Repeat; Secreted; Signal; Zinc; Zymogen. FT SIGNAL 1 29 {ECO:0000255}. FT PROPEP 30 253 {ECO:0000250}. FT /FTId=PRO_0000029158. FT CHAIN 254 1211 A disintegrin and metalloproteinase with FT thrombospondin motifs 2. FT /FTId=PRO_0000029159. FT DOMAIN 266 470 Peptidase M12B. {ECO:0000255|PROSITE- FT ProRule:PRU00276}. FT DOMAIN 480 560 Disintegrin. FT DOMAIN 561 616 TSP type-1 1. {ECO:0000255|PROSITE- FT ProRule:PRU00210}. FT DOMAIN 854 912 TSP type-1 2. {ECO:0000255|PROSITE- FT ProRule:PRU00210}. FT DOMAIN 914 971 TSP type-1 3. {ECO:0000255|PROSITE- FT ProRule:PRU00210}. FT DOMAIN 975 1029 TSP type-1 4. {ECO:0000255|PROSITE- FT ProRule:PRU00210}. FT DOMAIN 1059 1097 PLAC. {ECO:0000255|PROSITE- FT ProRule:PRU00233}. FT REGION 723 851 Spacer. FT MOTIF 691 693 Cell attachment site. {ECO:0000255}. FT COMPBIAS 40 43 Poly-Ala. FT COMPBIAS 185 188 Poly-Glu. FT COMPBIAS 618 722 Cys-rich. FT ACT_SITE 409 409 {ECO:0000255|PROSITE-ProRule:PRU00276}. FT METAL 408 408 Zinc; catalytic. {ECO:0000255|PROSITE- FT ProRule:PRU00276}. FT METAL 412 412 Zinc; catalytic. {ECO:0000255|PROSITE- FT ProRule:PRU00276}. FT METAL 418 418 Zinc; catalytic. {ECO:0000255|PROSITE- FT ProRule:PRU00276}. FT CARBOHYD 112 112 N-linked (GlcNAc...). {ECO:0000255}. FT CARBOHYD 251 251 N-linked (GlcNAc...). {ECO:0000255}. FT CARBOHYD 949 949 N-linked (GlcNAc...). {ECO:0000255}. FT CARBOHYD 993 993 N-linked (GlcNAc...). {ECO:0000255}. FT CARBOHYD 1031 1031 N-linked (GlcNAc...). {ECO:0000255}. FT CARBOHYD 1098 1098 N-linked (GlcNAc...). {ECO:0000255}. FT CARBOHYD 1145 1145 N-linked (GlcNAc...). {ECO:0000255}. FT CARBOHYD 1150 1150 N-linked (GlcNAc...). {ECO:0000255}. FT DISULFID 343 392 {ECO:0000250}. FT DISULFID 386 465 {ECO:0000250}. FT DISULFID 425 451 {ECO:0000250}. FT DISULFID 492 517 {ECO:0000250}. FT DISULFID 503 526 {ECO:0000250}. FT DISULFID 512 545 {ECO:0000250}. FT DISULFID 539 550 {ECO:0000250}. FT DISULFID 573 610 {ECO:0000250}. FT DISULFID 577 615 {ECO:0000250}. FT DISULFID 588 600 {ECO:0000250}. FT DISULFID 987 1023 {ECO:0000250}. FT DISULFID 991 1028 {ECO:0000250}. FT DISULFID 1002 1012 {ECO:0000250}. FT VAR_SEQ 544 566 HCFKGHCIWLTPDILKRDGSWGA -> FRPGAVAHACYPST FT LGGQGRWIA (in isoform SpNPI). FT {ECO:0000303|PubMed:10417273}. FT /FTId=VSP_005497. FT VAR_SEQ 567 1211 Missing (in isoform SpNPI). FT {ECO:0000303|PubMed:10417273}. FT /FTId=VSP_005498. FT VARIANT 74 74 V -> M (in dbSNP:rs2271211). FT /FTId=VAR_047927. FT VARIANT 241 241 R -> H (in dbSNP:rs11750821). FT /FTId=VAR_047928. FT VARIANT 245 245 V -> I (in dbSNP:rs398829). FT /FTId=VAR_020058. FT VARIANT 331 331 E -> K (in dbSNP:rs17667857). FT /FTId=VAR_047929. FT VARIANT 665 665 G -> R (in dbSNP:rs35372714). FT /FTId=VAR_047930. FT VARIANT 827 827 R -> Q (in dbSNP:rs35445112). FT /FTId=VAR_047931. FT VARIANT 1177 1177 P -> S (in dbSNP:rs1054480). FT /FTId=VAR_020059. FT CONFLICT 1001 1001 L -> P (in Ref. 1; CAA05880). FT {ECO:0000305}. FT CONFLICT 1089 1089 C -> S (in Ref. 1; CAA05880). FT {ECO:0000305}. SQ SEQUENCE 1211 AA; 134755 MW; 6C4F2C2D46A1F925 CRC64; MDPPAGAARR LLCPALLLLL LLLPPPLLPP PPPPANARLA AAADPPGGPL GHGAERILAV PVRTDAQGRL VSHVVSAATS RAGVRARRAA PVRTPSFPGG NEEEPGSHLF YNVTVFGRDL HLRLRPNARL VAPGATMEWQ GEKGTTRVEP LLGSCLYVGD VAGLAEASSV ALSNCDGLAG LIRMEEEEFF IEPLEKGLAA QEAEQGRVHV VYRRPPTSPP LGGPQALDTG ASLDSLDSLS RALGVLEEHA NSSRRRARRH AADDDYNIEV LLGVDDSVVQ FHGKEHVQKY LLTLMNIVNE IYHDESLGAH INVVLVRIIL LSYGKSMSLI EIGNPSQSLE NVCRWAYLQQ KPDTGHDEYH DHAIFLTRQD FGPSGMQGYA PVTGMCHPVR SCTLNHEDGF SSAFVVAHET GHVLGMEHDG QGNRCGDEVR LGSIMAPLVQ AAFHRFHWSR CSQQELSRYL HSYDCLLDDP FAHDWPALPQ LPGLHYSMNE QCRFDFGLGY MMCTAFRTFD PCKQLWCSHP DNPYFCKTKK GPPLDGTMCA PGKHCFKGHC IWLTPDILKR DGSWGAWSPF GSCSRTCGTG VKFRTRQCDN PHPANGGRTC SGLAYDFQLC SRQDCPDSLA DFREEQCRQW DLYFEHGDAQ HHWLPHEHRD AKERCHLYCE SRETGEVVSM KRMVHDGTRC SYKDAFSLCV RGDCRKVGCD GVIGSSKQED KCGVCGGDNS HCKVVKGTFT RSPKKHGYIK MFEIPAGARH LLIQEVDATS HHLAVKNLET GKFILNEEND VDASSKTFIA MGVEWEYRDE DGRETLQTMG PLHGTITVLV IPVGDTRVSL TYKYMIHEDS LNVDDNNVLE EDSVVYEWAL KKWSPCSKPC GGGSQFTKYG CRRRLDHKMV HRGFCAALSK PKAIRRACNP QECSQPVWVT GEWEPCSQTC GRTGMQVRSV RCIQPLHDNT TRSVHAKHCN DARPESRRAC SRELCPGRWR AGPWSQCSVT CGNGTQERPV LCRTADDSFG ICQEERPETA RTCRLGPCPR NISDPSKKSY VVQWLSRPDP DSPIRKISSK GHCQGDKSIF CRMEVLSRYC SIPGYNKLCC KSCNLYNNLT NVEGRIEPPP GKHNDIDVFM PTLPVPTVAM EVRPSPSTPL EVPLNASSTN ATEDHPETNA VDEPYKIHGL EDEVQPPNLI PRRPSPYEKT RNQRIQELID EMRKKEMLGK F //